Cargando…
Improved broad-spectrum antibiotics against Gram-negative pathogens via darobactin biosynthetic pathway engineering
The development of new antibiotics is imperative to fight increasing mortality rates connected to infections caused by multidrug-resistant (MDR) bacteria. In this context, Gram-negative pathogens listed in the WHO priority list are particularly problematic. Darobactin is a ribosomally produced and p...
Autores principales: | Groß, Sebastian, Panter, Fabian, Pogorevc, Domen, Seyfert, Carsten E., Deckarm, Selina, Bader, Chantal D., Herrmann, Jennifer, Müller, Rolf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442675/ https://www.ncbi.nlm.nih.gov/pubmed/34659729 http://dx.doi.org/10.1039/d1sc02725e |
Ejemplares similares
-
Darobactins Exhibiting Superior Antibiotic Activity by Cryo‐EM Structure Guided Biosynthetic Engineering
por: Seyfert, Carsten E., et al.
Publicado: (2022) -
Mutasynthetic Production and Antimicrobial Characterization of Darobactin Analogs
por: Böhringer, Nils, et al.
Publicado: (2021) -
Synergizing the potential of bacterial genomics and metabolomics to find novel antibiotics
por: Panter, Fabian, et al.
Publicado: (2021) -
Biotechnological production optimization of argyrins – a potent immunomodulatory natural product class
por: Pogorevc, Domen, et al.
Publicado: (2021) -
Gram stain-guided antibiotic choice: a GRACEful method to safely restrict overuse of broad-spectrum antibiotic agents
por: Yoshimura, Jumpei, et al.
Publicado: (2018)